Ramius Extends Tender Offer Expiration on Cypress Bioscience (CYPB)
Ramius LLC affiliates announced that they are extending their tender offer for all outstanding shares of Cypress Bioscience, Inc. (Nasdaq: CYPB) for expiry on January 5, 2011, at midnight.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- BofA (BAC), Barclays (BCS) to Sell Remaining Archstone Interest in $1.58B Deal to Lehman Bros.
- UPDATE: RR Donnelley (RRD) to Buy Edgar Online (EDGR) for $70.5M
- General Electric (GE) Makes $300M Investment in Large Brazilian Conglomerate
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
Ramius Capital, Cypress Bioscience/RamiusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
